贝达药业(300558.SZ)：上半年净利润1.4亿元 同比下降37.53%

Core Viewpoint - Beida Pharmaceutical (300558.SZ) reported a revenue of 1.731 billion yuan for the first half of the year, reflecting a year-on-year growth of 15.37%, while the net profit attributable to shareholders decreased by 37.53% to 140 million yuan [1] Financial Performance - The company's operating revenue reached 1.731 billion yuan, marking a 15.37% increase compared to the previous year [1] - The net profit attributable to shareholders was 140 million yuan, which represents a significant decline of 37.53% year-on-year [1] - The net profit excluding non-recurring gains and losses was 190 million yuan, showing a decrease of 11.97% compared to the same period last year [1]